Veracyte, Inc. announced that clinical validation data published in the journal CHEST show that the company’s Percepta Nasal Swab test determines lung cancer risk, with high accuracy, among people who currently smoke or have previously smoked and have lung nodules. The findings suggest that the novel, non-invasive genomic test can help...
BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, announced that it has won the 2023 Fierce Life Sciences Innovation Award for its AI-driven clinical trials selection tool. The program, produced by Fierce Biotech and Fierce Pharma, recognizes innovations that exemplify effectiveness, technical innovation, competitive advantage, financial impact, and true innovation with...
At the Radiological Society of North America's 109th Scientific Assembly and Annual Meeting, Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, announced it has teamed up with Nuance, a Microsoft company, to create the largest digital consultation network in...
Building on a promise to "pharmatize" artificial intelligence (AI) across the life sciences sector, EVERSANA, a leading provider of commercial services to the global life sciences industry, today announced the first of several new generative AI-based innovations on Amazon Web Services (AWS) to drive greater efficiency and business value for companies and...
Veeva Systems announced that Bayer will be among the first 20 major biopharmaceuticals to migrate to Veeva Vault CRM worldwide, while standardizing global data of customers with Veeva OpenData . As Bayer moves to Vault CRM, the next generation of CRM for life sciences, it is harmonizing customer reference data for greater efficiency and continued innovation...
Roche announced the launch of Elecsys HBeAg quant, an immunoassay that is able to determine both the presence and quantity of the hepatitis B e antigen in human serum and plasma. This launch means that, when combined with other laboratory results and clinical information, patients will now get confirmation...
STEMCELL Technologies, Canada's largest biotechnology company, has received the 2023 Canada's Most Admired Corporate Cultures award from Waterstone Human Capital. This national awards program recognizes best-in-class Canadian organizations for driving high-performance corporate cultures that help sustain a competitive advantage.
Also Read: Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of...
Veracyte, Inc. announced that seven posters will be presented at the 24th Annual Meeting of the Society of Urologic Oncology (SUO 2023), where they will demonstrate the clinical performance of Veracyte’s Decipher Prostate Genomic Classifier in identifying patients whose prostate cancer is likely to progress and require treatment. Collectively, the posters...
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), announced that Ronald Filippo has been appointed Chief Information Officer.
Mr. Filippo has more than 25 years of digital experience in the biopharmaceutical industry and was previously Senior Vice President Digital at Moderna, where he was...
Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies
Certara, Inc., a global leader in biosimulation, announced the introduction of Simcyp™ Biopharmaceutics software. It is designed for use by biopharmaceutic, formulation, and CMC scientists to aid in formulating complex novel and generic small...
